Literature DB >> 17030252

Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria.

Lucyna Mastalerz, Marek Sanak, Agnieszka Gawlewicz, Anna Gielicz, Jacek Faber, Andrew Szczeklik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030252     DOI: 10.1016/j.jaci.2006.06.028

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

1.  Cross-reactivity and tolerability of celecoxib in adult patients with NSAID hypersensitivity.

Authors:  Lily Li; Tanya Laidlaw
Journal:  J Allergy Clin Immunol Pract       Date:  2019-05-14

2.  Salicylate intolerance: a masquerader of multiple adverse drug reactions.

Authors:  Suran Loshana Fernando; Lesley R Clarke
Journal:  BMJ Case Rep       Date:  2009-09-15

3.  Exhaled Eicosanoids following Bronchial Aspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity: The Pilot Study.

Authors:  L Mastalerz; M Sanak; J Kumik; A Gawlewicz-Mroczka; N Celejewska-Wójcik; A Cmiel; A Szczeklik
Journal:  J Allergy (Cairo)       Date:  2012-01-12

Review 4.  Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature.

Authors:  Tobias Bernd Weberschock; Sylke-Monina Müller; Sandra Boehncke; Wolf-Henning Boehncke
Journal:  Arch Dermatol Res       Date:  2007-05-11       Impact factor: 3.017

5.  Cross-reactivity to Acetaminophen and Celecoxib According to the Type of Nonsteroidal Anti-inflammatory Drug Hypersensitivity.

Authors:  Yoon-Jeong Kim; Kyung-Hwan Lim; Mi-Young Kim; Eun-Jung Jo; Suh-Young Lee; Seung-Eun Lee; Min-Suk Yang; Woo-Jung Song; Hye-Ryun Kang; Heung-Woo Park; Yoon-Seok Chang; Sang-Heon Cho; Kyung-Up Min; Sae-Hoon Kim
Journal:  Allergy Asthma Immunol Res       Date:  2013-12-13       Impact factor: 5.764

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.